The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease

被引:75
|
作者
Pimentel-Coelho, Pedro M.
Rivest, Serge [1 ]
机构
[1] Univ Laval, CHUQ Res Ctr CHUL, Lab Endocrinol & Genom, Quebec City, PQ G1V 4G2, Canada
基金
加拿大健康研究院;
关键词
angiogenesis; cerebral ischemia; chronic cerebral hypoperfusion; neurogenesis; stroke; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; WHITE-MATTER LESIONS; CIRCULATING ANGIOGENIC CELLS; CAROTID-ARTERY OCCLUSION; MARROW-DERIVED MICROGLIA;
D O I
10.1111/j.1460-9568.2012.08126.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimers disease (AD) and cerebrovascular disorders are the leading causes of dementia in our ageing population. Given that the progression of neuropathological changes in the brains of AD patients initiates several years, and even decades, before the diagnosis of dementia, a great effort has been made to identify potentially modifiable factors that contribute to the pathogenesis of sporadic late-onset AD. Among these factors, cerebrovascular disease and microvascular alterations seem to bilaterally interact with the underlying AD pathology, affecting the progression of cognitive deficits. In addition, cerebrovascular dysfunction has emerged as an early event in AD, encompassing changes in virtually all cell types of the neurovascular unit, including bone marrow-derived cells, astrocytes, pericytes, vascular smooth muscle cells and endothelial cells. In this review, we discuss recent studies implicating cerebrovascular factors in the pathogenesis of AD. We also discuss how the impairment of mechanisms of brain regeneration, such as neurogenesis and angiogenesis, might be related to the vascular dysfunction. Finally, we briefly discuss several therapeutic options targeting the vascular system, which might represent an interesting strategy for preventing or delaying the onset of dementia in AD.
引用
收藏
页码:1917 / 1937
页数:21
相关论文
共 50 条
  • [1] Are cerebrovascular factors involved in Alzheimer's disease?
    Kudo, T
    Imaizumi, K
    Tanimukai, H
    Katayama, T
    Sato, N
    Nakamura, Y
    Tanaka, T
    Kashiwagi, Y
    Jinno, Y
    Tohyama, M
    Takeda, M
    NEUROBIOLOGY OF AGING, 2000, 21 (02) : 215 - 224
  • [2] Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications
    Jurcau, Anamaria
    Simion, Aurel
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020, 19 (02) : 94 - 108
  • [3] Vascular factors in the pathogenesis of Alzheimer's disease
    Lange-Asschenfeldt, C.
    NERVENARZT, 2013, 84 (06): : 732 - 737
  • [4] Environmental factors in the pathogenesis of Alzheimer's disease
    Jankowsky, Joanna L.
    NEUROSCIENCE RESEARCH, 2006, 55 : S41 - S41
  • [5] Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease
    Esiri, MM
    Nagy, Z
    Smith, MZ
    Barnetson, L
    Smith, AD
    LANCET, 1999, 354 (9182): : 919 - 920
  • [6] DYNAMIC FACTORS IN PATHOGENESIS OF CEREBROVASCULAR DISEASE
    MANCALL, EL
    HIRSCHHORN, AM
    GERIATRICS, 1967, 22 (03) : 168 - +
  • [7] Contribution of Cerebrovascular Health to the Diagnosis of Alzheimer Disease
    Rodrigue, Karen M.
    JAMA NEUROLOGY, 2013, 70 (04) : 438 - 439
  • [8] Cerebrovascular Risk Factors in Elderly Patients With Alzheimer's Disease
    Nagata, Ken
    Yamazaki, Takashi
    Takano, Daiki
    STROKE, 2019, 50
  • [9] Neurotrophic factors in Alzheimer's disease: pathogenesis and therapy
    Luebke, Joachim H. R.
    Idoon, Faezeh
    Mohasel-Roodi, Mina
    Alipour, Fatemeh
    Hami, Javad
    Ehteshampour, Alireza
    Mostafaee, Hamideh
    Sadeghi, Akram
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2021, 81 (04) : 314 - 327
  • [10] Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach
    Li, Song
    Wang, Che
    Wang, Zhen
    Tan, Jun
    AGING-US, 2021, 13 (17): : 21791 - 21806